Abbott Laboratories
ABT
$133.70
Share price
-0.55%
Change (1 day)
30.92%
Change (1 year)
Categories
Abbott Laboratories (ABT), (founding name: Abbott Alkaloid Company) is a global pharmaceutical company with around 73,000 employees in 150 countries. Abbott was founded in 1888 by Wallace C. Abbott (1857-1921) and is headquartered in Abbott Park, a northern suburb of Chicago, Illinois.
Abbott Laboratories (ABT) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : $32.38 Billion USD
According to Abbott Laboratories's latest financial reports the company's total liabilities are $32.38 Billion USD. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Abbott Laboratories - Total liabilities on balance sheet (from 2001 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | $33.51 B | -2.54% |
| 2023-12-31 | $34.38 B | -8.38% |
| 2022-12-31 | $37.53 B | -4.18% |
| 2021-12-31 | $39.17 B | -0.94% |
| 2020-12-31 | $39.54 B | 8.09% |
| 2019-12-31 | $36.58 B | 0.37% |
| 2018-12-31 | $36.45 B | -19.27% |
| 2017-12-31 | $45.15 B | 41.33% |
| 2016-12-31 | $31.94 B | 60.38% |
| 2015-12-31 | $19.92 B | 1.8% |
| 2014-12-31 | $19.56 B | 10.64% |
| 2013-12-31 | $17.68 B | -56.25% |
| 2012-12-31 | $40.42 B | 13.07% |
| 2011-12-31 | $35.75 B | -5.44% |
| 2010-12-31 | $37.80 B | 28.09% |
| 2009-12-31 | $29.51 B | 18.54% |
| 2008-12-31 | $24.90 B | 13.52% |
| 2007-12-31 | $21.93 B | -0.85% |
| 2006-12-31 | $22.12 B | 50.24% |
| 2005-12-31 | $14.72 B | 1.97% |
| 2004-12-31 | $14.44 B | 11.37% |
| 2003-12-31 | $12.96 B | -4.62% |
| 2002-12-31 | $13.59 B | -4.51% |
| 2001-12-31 | $14.23 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $115.56 B | 256.85% | 🇺🇸 USA |
 Pfizer PFE | $117.39 B | 262.50% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | $49.55 B | 53.03% | 🇺🇸 USA |
 Hologic HOLX | $3.92 B | -87.88% | 🇺🇸 USA |
 Medtronic MDT | $43.42 B | 34.09% | 🇮🇪 Ireland |
 Bristol-Myers Squibb BMY | $74.97 B | 131.53% | 🇺🇸 USA |
 Boston Scientific BSX | $17.69 B | -45.36% | 🇺🇸 USA |
 AstraZeneca AZN | $65.12 B | 101.09% | 🇬🇧 UK |
 Novartis NVS | $61.48 B | 89.87% | 🇨🇭 Switzerland |
 GlaxoSmithKline GSK | $60.79 B | 87.73% | 🇬🇧 UK |